IRadimed CorporationIRMDNASDAQ
Loading
Cash Flow PerformanceStrong
Percentile Rank92
3Y CAGR+28.1%
5Y CAGR+27.1%
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

3Y CAGR
+28.1%/yr
vs +3.5%/yr prior
5Y CAGR
+27.1%/yr
Consistent
Acceleration
+24.6pp
Accelerating
Percentile
P92
Near historical high
vs 5Y Ago
3.3x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
2025$17.18M-2.5%
2024$17.62M+222.8%
2023$5.46M-33.2%
2022$8.17M-22.3%
2021$10.52M+103.0%
2020$5.18M-46.8%
2019$9.75M+37.1%
2018$7.11M+174.4%
2017$2.59M-67.1%
2016$7.88M-